Gizem Tutkun

Ms. Gizem Tutkun

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2025 in Viruses
Verified
Journal Article
Open access
PDF file
MOMustafa Ozdogan
Mustafa Ozdogan
GTGizem Tutkun
Gizem Tutkun
MCMuharrem Okan Cakir
Muharrem Okan Cakir
GAG. Hossein Ashrafi
G. Hossein Ashrafi
Human papillomavirus (HPV) plays a major role in the development of head and neck cancers (HNCs), particularly oropharyngeal squamous cell carcinoma. This review highlights the key molecular mechanisms of HPV-driven carcinogenesis, focusing on the oncogenic E6 and E7 proteins and their disruption of tumor suppressor pathways and epigenetic regulation. We discuss the rising prevalence of HPV-related HNCs, their distinct clinical features, and diagnostic approaches such as p16 immunohistochemistry and HPV DNA/RNA detection. HPV-positive tumors show better prognosis and response to treatment, prompting interest in therapy de-escalation. Emerging strategies including immune checkpoint inhibitors, therapeutic vaccines, CRISPR-based gene editing, and ctDNA monitoring are advancing precision oncology in this field. We also examine the preventive potential of HPV vaccination and ongoing research into its role across various HNC subtypes. A deeper understanding of HPV’s molecular impact may guide more effective, targeted, and less toxic interventions.

22 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MOMustafa Ozdogan
Mustafa Ozdogan
GTGizem Tutkun
Gizem Tutkun
MCMuharrem Okan Cakir
Muharrem Okan Cakir
GAG. Hossein Ashrafi
G. Hossein Ashrafi
Human papillomavirus (HPV) plays a major role in the development of head and neck cancers (HNCs), particularly oropharyngeal squamous cell carcinoma. This review highlights the key molecular mechanisms of HPV-driven carcinogenesis, focusing on the oncogenic E6 and E7 proteins and their disruption of tumor suppressor pathways and epigenetic regulation. We discuss the rising prevalence of HPV-related HNCs, their distinct clinical features, and diagnostic approaches such as p16 immunohisto-chemistry and HPV DNA/RNA detection. HPV-positive tumors show better prognosis and response to treatment, prompting interest in therapy de-escalation. Emerging strategies including immune checkpoint inhibitors, therapeutic vaccines, CRISPR-based gene editing, and ctDNA monitoring are advancing precision oncology in this field. We also examine the preventive potential of HPV vaccination and ongoing research into its role across various HNC subtypes. A deeper understanding of HPV’s molecular impact may guide more effective, targeted, and less toxic interventions.

28 March 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
GTGizem Tutkun
Gizem Tutkun
MCMuharrem Okan Cakir
Muharrem Okan Cakir
GAG. Hossein Ashrafi
G. Hossein Ashrafi
MOMustafa Ozdogan
Mustafa Ozdogan
Ugur BilgeUgur Bilge
Ugur Bilge
Bromodomain and Extra-Terminal (BET) proteins are crucial epigenetic regulators involved in transcriptional processes linked to cancer progression. Inhibiting these proteins has emerged as a promising therapeutic strategy, with OTX015, a potent BET inhibitor, showing promising efficacy against various cancer types. However, accurately predicting drug sensitivity across cancer cell lines remains a challenge. In this study, we present a machine learning-based approach to predict the half-maximal inhibitory concentration (IC₅₀) of OTX015 across various cancer cell lines using their gene expression profiles. By employing regression-based machine learning models, including Support Vector Machine (SVM), K-Nearest Neighbor (KNN), Extreme Gradient Boosting (XGB), Elastic Net (EN), and Neural Networks (NNET), we aimed to optimize prediction accuracy. The dataset was divided into subsets containing 10, 25, 50, 75, and 100 genes based on their correlation with IC₅₀ values, enabling a comprehensive evaluation of model performance across different data dimensions. The SVM model consistently demonstrated the best performance, achieving the lowest Mean Absolute Error (MAE) scores across all datasets, thereby proving most effective for predicting IC₅₀ values. This approach highlights the potential of integrating machine learning algorithms with gene expression data to enhance drug discovery and personalized medicine, particularly in the context of cancer research. Future work should focus on expanding datasets, optimizing feature selection, and evaluating additional machine learning approaches to improve prediction reliability and generalizability.

29 June 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
GTGizem Tutkun
Gizem Tutkun
MCMuharrem Okan Cakir
Muharrem Okan Cakir
Ugur BilgeUgur Bilge
Ugur Bilge
The focus was on developing machine learning models to predict the IC50 values of the compound OTX015 using gene expression levels of cancer cell lines. Through regression-based machine learning models, particularly the SVM model, trained on pre-laboratory data, consistent and generalizable performance with low error scores was achieved. These models underwent enhancement via hyperparameter optimization and were tested on validation data. The results indicate the utility of machine learning in drug discovery processes and personalized medicine, offering rapid and cost-effective predictions of IC50 values. However, for enhanced reliability, further model development, data gathering, and evaluation with diverse compounds are recommended. In conclusion, this research demonstrates the potential of machine learning approaches to optimize experimental processes, reduce costs, and contribute to personalized treatments in healthcare by accurately predicting compound responses.

27 July 2026 in Eskişehir Teknik Üniversitesi Bilim ve Teknoloji Dergisi - C Yaşam Bilimleri ve Biyoteknoloji
Verified
Journal Article
Closed access
EAEsra Tanyel Akcit
Esra Tanyel Akcit
NBNüket Akanıl Bingöl
Nüket Akanıl Bingöl
EŞEce Şimşek
Ece Şimşek
AAAltınay Altınkaynak
Altınay Altınkaynak
GTGizem Tutkun
Gizem Tutkun
ACAhmet Yilmaz Coban
Ahmet Yilmaz Coban
Lung cancer is still one of the main causes of cancer-related mortality worldwide. Angiogenesis plays a vital role in tumor progression and metastasis. Natural products have acted as valuable resources in drug discovery due to their diverse biological activities and rich content of bioactive secondary metabolites. Symphytum officinale L. is a medicinal plant known for its high phenolic content and has attracted research interest for various biological properties. However, its angiogenesis-related effects have not yet been clearly characterized. In this study, the phenolic content and antioxidant capacity of S. officinale extracts were determined, and their effects on A549 lung cancer cell proliferation were evaluated using the MTT assay. The levels of substance P, vascular endothelial growth factor, and interleukin-6 released from A549 lung carcinoma cells were quantified by ELISA. In addition, molecular docking analyses were performed to investigate the interactions of malaxinic acid and globoidnan A with receptors associated with substance P, vascular endothelial growth factor, and interleukin-6 signaling pathways. The S. officinale extract significantly reduced the viability and proliferation of A549 lung cancer cells. ELISA assays revealed a significant reduction (p